NCT03899220

Brief Summary

This study will implement a pilot randomized controlled trial (RCT, N=60) to assess the feasibility and acceptability a refined emotion regulation intervention designed to improve engagement in HIV-care among substance using HIV+ MSM sub-optimally engaged in HIV care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2019

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 2, 2019

Completed
22 days until next milestone

Study Start

First participant enrolled

April 24, 2019

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2023

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2025

Completed
Last Updated

December 8, 2025

Status Verified

December 1, 2025

Enrollment Period

4.1 years

First QC Date

March 27, 2019

Last Update Submit

December 1, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Acceptability of Intervention

    The summary score of the Client Satisfaction Questionnaire (CSQ-8) (Sum of 8 questions with response options ranging from 1-4).

    change from baseline to 12 weeks after intervention completion

  • Feasibility of Intervention

    Percent of sessions completed (≥70% considered indicative of feasibility) and percent of text messages responded to by participants (≥70% considered indicative of feasibility).

    change from baseline to 12 weeks after intervention completion

Secondary Outcomes (1)

  • Engagement in HIV Care

    change from baseline to 12 weeks after intervention completion

Study Arms (2)

Intervention

EXPERIMENTAL

This intervention includes 5 face-to-face therapy sessions with a trained clinician plus a bidirectional text component that queries mood, substance use, and medication adherence.

Behavioral: Project Matter

Enhanced Treatment as Usual (E-TAU)

ACTIVE COMPARATOR

Enhanced treatment as usual includes a one session behavioral engagement in care intervention as well as substance use treatment counseling.

Behavioral: Project Matter

Interventions

Project MatterBEHAVIORAL

This intervention includes 5 face-to-face therapy sessions with a trained clinician plus a bidirectional text component that queries mood, substance use, and medication adherence. Both the intervention group and the enhanced treatment as usual (E-TAU) involve a one-session behavioral engagement in care intervention as well as substance use treatment counseling.

Enhanced Treatment as Usual (E-TAU)Intervention

Eligibility Criteria

Age18 Years+
Sexmale(Gender-based eligibility)
Gender Eligibility DetailsCisgender men who have sex with men
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • HIV positive
  • Cisgender male
  • Man who has sex with men (MSM)
  • Elevated levels of internalized stigma related to HIV, substance use, or homophobia
  • Poorly engaged in HIV care
  • Able to provide informed consent
  • years or older
  • English speaking

You may not qualify if:

  • Women
  • Non-cisgender men
  • Do not identify as gay, bisexual, or MSM

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fenway Community Health

Boston, Massachusetts, 02215, United States

Location

MeSH Terms

Conditions

Substance-Related DisordersAcquired Immunodeficiency SyndromeHomosexuality, Male

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersHIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System DiseasesHomosexualitySexualitySexual BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Pilot Randomized Controlled Trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor and Staff Psychologist

Study Record Dates

First Submitted

March 27, 2019

First Posted

April 2, 2019

Study Start

April 24, 2019

Primary Completion

May 30, 2023

Study Completion

December 1, 2025

Last Updated

December 8, 2025

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations